The investigators will examine the toxicity of therapeutic doses of paracetamol in patients
in severe sepsis. Patients with fever and severe sepsis will be randomized to receive
paracetamol or dypirone. The investigators will monitor blood glutathione and liver enzymes
to look for potential toxicity.